The role of genomic diversity in clinically high-risk prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210751
- Recipient
-
University Of California, LOS Angeles UEI RN64EPNH8JC6 Part of State Of California Controllers Office
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,169,966
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Los Angeles, CA 90024, USA
Award details come from USAspending.gov.
About this award
The University of California, Los Angeles will receive $1,169,966 under a three-year Project Grant from the Department of the Army Medical Command titled "The Role of Genomic Diversity in Clinically High-Risk Prostate Cancer." The grant is part of the Military Medical Research and Development program administered by the Department of Defense and aims to transform military and public health through innovative medical research.
Specifically, UCLA will investigate the role of genomic diversity in clinically high-risk prostate cancer from August 2022 through July 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with a focus on developing medical solutions for service members and the general public. Insights from this research could help improve screening and treatment for high-risk prostate cancer, a goal that would benefit both military and civilian health.
Quick answers
Who received award W81XWH2210751?
W81XWH2210751 was awarded to University Of California, LOS Angeles by Medical Command (Department of the Army) on August 1, 2022.
How much is award W81XWH2210751 worth?
$1,169,966 has been obligated on W81XWH2210751.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award